-
Article
Open AccessCorrection to: Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management
-
Article
Open AccessPersons with multiple sclerosis older than 55 years: an analysis from the German MS registry
Persons with MS (PwMS) ≥ 55 years are underrepresented in therapy studies leading to a lack of evidence.
-
Article
Open Access“So at least now I know how to deal with things myself, what I can do if it gets really bad again”—experiences with a long-term cross-sectoral advocacy care and case management for severe multiple sclerosis: a qualitative study
Persons with severe Multiple Sclerosis (PwsMS) face complex needs and daily limitations that make it challenging to receive optimal care. The implementation and coordination of health care, social services, an...
-
Article
Open AccessCognitive decline in post-COVID-19 syndrome does not correspond with persisting neuronal or astrocytic damage
Cognitive impairment is the most frequent symptom reported in post-COVID-19 syndrome (PCS). Aetiology of cognitive impairment in PCS is still to be determined. Neurofilament light chain (NfL) and glial fibrill...
-
Article
Open AccessCerebrospinal fluid findings in patients with neurological manifestations in post-COVID-19 syndrome
Information on cerebrospinal fluid (CSF) findings in patients with neurological manifestations in post-COVID-19 syndrome is scarce.
-
Article
Open AccessUpdate on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management
This manuscript presents practical recommendations for managing acute attacks and implementing preventive immunotherapies for neuromyelitis optica spectrum disorders (NMOSD), a rare autoimmune disease that cau...
-
Article
Open AccessMultidomain cognitive impairment in non-hospitalized patients with the post-COVID-19 syndrome: results from a prospective monocentric cohort
A fraction of patients with asymptomatic to mild/moderate acute COVID-19 disease report cognitive deficits as part of the post-COVID-19 syndrome. This study aimed to assess the neuropsychological profile of th...
-
Chapter
Entzündliche und erregerbedingte Erkrankungen
Das Kapitel enthält sechs beispielhafte kommentierte Arztbriefe zu entzündlichen und erregerbedingten Erkrankungen wie der Multiplen Sklerose, Neuromyelitis-optica-Spektrum-Erkrankungen, limbischer Enzephaliti...
-
Article
Open AccessFitness, physical activity, and exercise in multiple sclerosis: a systematic review on current evidence for interactions with disease activity and progression
A moderate to high level of physical activity, including regular exercise, represents an established behavioral and rehabilitative approach for persons with multiple sclerosis (pwMS). Although being increasing...
-
Article
Open AccessInnovative therapeutic concepts of progressive multifocal leukoencephalopathy
Progressive multifocal leukoencephalopathy (PML) is an opportunistic viral disease of the brain—caused by human polyomavirus 2. It affects patients whose immune system is compromised by a corresponding underly...
-
Article
Open AccessHemiparese bei Klappenvegetationen und Panzytopenie
-
Article
Open AccessAbsolute serum neurofilament light chain levels and its early kinetics predict brain injury after out-of-hospital cardiac arrest
To test if the early kinetics of neurofilament light (NFL) in blood adds to the absolute values of NFL in the prediction of outcome, and to evaluate if NFL can discriminate individuals with severe hypoxic–isch...
-
Article
Open AccessTherapy Switches in Fingolimod-Treated Patients with Multiple Sclerosis: Long-Term Experience from the German MS Registry
Therapy switches in patients with multiple sclerosis (MS) receiving treatment with fingolimod occur frequently in clinical practice but are not well represented in real-world data. The aim of this study was to...
-
Article
S2k-Leitlinie der DGN zur Therapie der multiplen Sklerose: zielgerichteter Einsatz von Immuntherapien
-
Article
Open AccessSecondary Immunodeficiency and Risk of Infection Following Immune Therapies in Neurology
Secondary immunodeficiencies (SIDs) are acquired conditions that may occur as sequelae of immune therapy. In recent years a number of disease-modifying therapies (DMTs) has been approved for multiple sclerosis...
-
Article
Open AccessSuccessful treatment of thromboses of major arteries after ChAdOx1 nCov-19 vaccination
The ChAdOx1 nCoV-19 adenoviral vector vaccine to prevent contracting Covid-19 caused by infection with SARS-CoV-2 has been associated with vaccine-induced immune thrombotic thrombocytopenia (VITT) primarily le...
-
Article
Open AccessChances and challenges of a long-term data repository in multiple sclerosis: 20th birthday of the German MS registry
In 2001, the German Multiple Sclerosis Society, facing lack of data, founded the German MS Registry (GMSR) as a long-term data repository for MS healthcare research. By the establishment of a network of partic...
-
Article
Erratum zu: Toxizitäten nach Chimärer-Antigenrezeptor-T-Zell-Therapie
-
Article
Toxizitäten nach Chimärer-Antigenrezeptor-T-Zell-Therapie
Die Transfusion von Chimären-Antigenrezeptor(CAR)-T-Zellen hat sich als neue Therapieform in der Onkologie etabliert, geht jedoch regelhaft mit immunvermittelten Nebenwirkungen einher, die auch schwer verlaufe...
-
Article
Open AccessA systematic review of neurological symptoms and complications of COVID-19
To study the frequency of neurological symptoms and complications in COVID-19 patients in a systematic review of the literature.
